Zirconium silicate - ZS Pharma
Alternative Names: LOKELMA; Lokelma; Sodium zirconium cyclosilicate; UXSi-9; Ziconite; Zircon; ZS; ZS 9Latest Information Update: 17 May 2024
At a glance
- Originator ZS Pharma
- Developer AstraZeneca; ZS Pharma
- Class Heavy metals; Minerals; Silicates; Transition elements; Urologics
- Mechanism of Action Potassium binding modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Hyperkalaemia
- Phase III Kidney disorders